Results 141 to 150 of about 36,764 (181)
Some of the next articles are maybe not open access.
Drugs, 1988
Lovastatin and simvastatin are the 2 best-known members of the class of hypolipidaemic agents known as HMG CoA reductase inhibitors. Clinical experience with lovastatin includes over 5000 patients, 700 of whom have been treated for 2 years or more, and experience with simvastatin includes over 3500 patients, of whom 350 have been treated for 18 months ...
openaire +2 more sources
Lovastatin and simvastatin are the 2 best-known members of the class of hypolipidaemic agents known as HMG CoA reductase inhibitors. Clinical experience with lovastatin includes over 5000 patients, 700 of whom have been treated for 2 years or more, and experience with simvastatin includes over 3500 patients, of whom 350 have been treated for 18 months ...
openaire +2 more sources
Current Opinion in Lipidology, 1992
HMG CoA (β-hydroxy-β-methylglutaryl coenzyme A) reductase inhibitors are very effective in lowering total and low-density lipoprotein cholesterol. The incidence of adverse effects is very low with elevated transaminase levels and myopathy being of greatest concern.
openaire +1 more source
HMG CoA (β-hydroxy-β-methylglutaryl coenzyme A) reductase inhibitors are very effective in lowering total and low-density lipoprotein cholesterol. The incidence of adverse effects is very low with elevated transaminase levels and myopathy being of greatest concern.
openaire +1 more source
Bile acid derived HMG-CoA reductase inhibitors
Biochimica Et Biophysica Acta - Molecular Basis of Disease, 1994Werner Kramer, G Wess, Alfons Enhsen
exaly
Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors
Nature Reviews Drug Discovery, 2003Jonathan A Tobert
exaly